Tumor vasculature remodeling by radiation therapy increases doxorubicin distribution and efficacy.
Animals
Antibiotics, Antineoplastic
/ metabolism
Carcinoma, Lewis Lung
/ blood supply
Chemoradiotherapy
Doxorubicin
/ metabolism
Female
Humans
Male
Mice, Inbred C57BL
Mice, Nude
Neovascularization, Pathologic
PC-3 Cells
Prostatic Neoplasms
/ blood supply
Radiation Dosage
Tissue Distribution
Tumor Burden
/ drug effects
Tumor Hypoxia
Tumor Microenvironment
Vascular Remodeling
/ radiation effects
Xenograft Model Antitumor Assays
Chemotherapy
Drug distribution
Pericyte
Radiotherapy
Vascular normalization
Journal
Cancer letters
ISSN: 1872-7980
Titre abrégé: Cancer Lett
Pays: Ireland
ID NLM: 7600053
Informations de publication
Date de publication:
10 08 2019
10 08 2019
Historique:
received:
20
09
2018
revised:
30
04
2019
accepted:
06
05
2019
pubmed:
13
5
2019
medline:
28
4
2020
entrez:
13
5
2019
Statut:
ppublish
Résumé
The tumor microenvironment regulates cancer initiation, progression and response to treatment. In particular, the immature tumor vasculature may impede drugs from reaching tumor cells at a lethal concentration. We and others have shown that radiation therapy (RT) induces pericyte recruitment, resembling vascular normalization. Here, we asked whether radiation-induced vascular remodeling translates into improved tissue distribution and efficacy of chemotherapy. First, RT induced vascular remodeling, accompanied by decreased hypoxia and/or increased Hoechst perfusion in prostate PC3 and LNCaP and Lewis lung carcinoma. These results were independent of the RT regimen, respectively 10 × 2 Gy and 2 × 12 Gy, suggesting a common effect. Next, using doxorubicin as a fluorescent reporter, we observed that RT improves intra-tumoral chemotherapy distribution. These effects were not hindered by anti-angiogenic sunitinib. Moreover, sub-optimal doses of doxorubicin had almost no effect alone, but significantly delayed tumor growth after RT. These data demonstrate that RT favors the efficacy of chemotherapy by improving tissue distribution, and could be an alternative chemosensitizing strategy.
Identifiants
pubmed: 31078733
pii: S0304-3835(19)30281-2
doi: 10.1016/j.canlet.2019.05.005
pii:
doi:
Substances chimiques
Antibiotics, Antineoplastic
0
Doxorubicin
80168379AG
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-9Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.